Transcription Factor Induction of Nucleus Pulposus Progenitor Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for intervertebral disc degeneration, such as transplanting nucleus pulposus cells or stem cells, face challenges including reproducibility, cost, and the inability to maintain the active nucleus pulposus cell phenotype, with limited effectiveness and safety of using growth factors for differentiation induction.
Innovation Solution
The use of a combination of Brachyury (T), SRY-box6 (SOX6), Forkhead Box Q1 (FOXQ1), and MYC Proto-Oncogene (cMyc) transcription factors to induce nucleus pulposus progenitor cells from terminally differentiated cells, enhancing their proliferative capacity and extracellular matrix production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleus pulposus cells or stem cells are transplanted to treat intervertebral disc degeneration, then regenerative effect is achieved, but reproducibility and cost control are poor
Solution Approach 1:
The invention changes the fundamental parameter of cell production from surgical extraction to in vitro differentiation. By using transcription factor overexpression (T, SOX6, FOXQ1, cMyc) to induce nucleus pulposus cell differentiation from mesenchymal stem cells in a controlled laboratory setting, the process achieves high reproducibility and cost-effectiveness while maintaining regenerative efficacy.
Solution Approach 2:
The invention replaces the mechanical/surgical system of cell extraction and transplantation with a biochemical system of transcription factor-mediated differentiation. This substitution enables scalable, standardized production of nucleus pulposus cells through molecular mechanisms rather than relying on donor surgery and tissue processing.
2Productivity
If growth factors are used for differentiation induction, then cell differentiation is achieved, but reproducibility and safety are insufficient
Solution Approach 1:
The invention extracts and directly applies the core regulatory mechanism (transcription factors T, SOX6, FOXQ1, cMyc) that controls nucleus pulposus cell differentiation, eliminating the need for complex growth factor combinations. This extraction of the essential regulatory elements simplifies the process, improves reproducibility, and enhances safety by reducing unknown variables in the differentiation protocol.
3Reliability
If active nucleus pulposus cell phenotype is maintained, then regenerative capacity is improved, but cell proliferation capacity is limited
Solution Approach 1:
The invention performs preliminary action by overexpressing transcription factors (T, SOX6, FOXQ1, cMyc) during the differentiation process to simultaneously establish both the active nucleus pulposus cell phenotype and high proliferation capacity. This preliminary molecular programming ensures that the differentiated cells inherit both functional characteristics and proliferative potential from the outset.
Solution Approach 2:
The invention uses a composite approach by combining multiple transcription factors (T, SOX6, FOXQ1, cMyc) that work synergistically to achieve both phenotype maintenance and proliferation. This composite molecular strategy allows simultaneous optimization of both functional and proliferative properties that cannot be achieved by single-factor intervention.
Data Source
AI summary
Provided is reproducible means that enables production of nucleus pulposus progenitor cells (preferably, an active nucleus pulposus progenitor cell phenotype) from desired cells such as terminally differentiated cells and stem cells having pluripotency or multipotency. A nucleus pulposus progenitor cell inducer according to the present invention comprising an effective amount of a gene of Brachyury (T) or a homolog thereof, at least one selected from the group consisting of SRY-box6 (SOX6) or a homolog thereof and Forkhead Box Q1 (FOXQ1) or a homolog thereof, and MYC Proto-Oncogene, BHLH Transcription Factor (cMyc) or a homolog thereof (nucleus pulposus progenitor cell master regulator transcription factor), or a product thereof.